GlobalData on MSN
FDA approves Anumana’s pulmonary hypertension algorithm
The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data transfer.
A system-wide approach The new tool, called the UC Way Hypertension Medication Algorithm, follows a stepwise approach to increasing medication types and doses, while allowing clinicians to adjust ...
Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.
Please provide your email address to receive an email when new articles are posted on . At diagnosis, the area under the receiver operating characteristic curve in two test sets was 0.92 and 0.88.
Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results